Protara Therapeutics, Inc.’s TARA share price has dipped by 18.87%, which has investors questioning if this is right time to buy.

Protara Therapeutics (TARA) appears an attractive pick ... which is one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture.

Analyst Price Forecast Suggests 511.51% Upside As of April 2, 2025, the average one-year price target for Protara Therapeutics is $25.50/share. The forecasts range from a low of $22.22 to a high ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...